The
global infectious disease diagnostics market is expected to reach USD 25.43
billion by 2027 from USD 15.57 billion in 2018, at a CAGR of 5.6%.
The increasing global prevalence of infectious diseases, the
shift in focus from centralized laboratories to decentralized point-of-care
testing, and growth in funding for research on infectious disease diagnostics
are some the factors driving the growth of this market.
Growth in this market is primarily driven by the increasing
global prevalence of infectious diseases, shift in focus from centralized
laboratories to decentralized point-of-care testing, and growth in funding for
research on infectious disease diagnostics
Download PDF
Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=116764589
The global infectious
disease diagnostics market segmentation:
·
Based on the disease type,
·
Based on end user
·
Based on technology
The Major Players
Opearting in Infectious Disease Diagnostics Market :
The key players in the global infectious disease diagnostics
market are Abbott (US), Becton, Dickinson and Company (BD) (US), biomérieux (France),
Bio-Rad (US), and Roche (Switzerland). These players focus on inorganic
strategies such as acquisitions, partnerships, agreements, collaborations and
as well as organic strategies such as expansions and product launches &
approvals to sustain their growth in the market.
Geographical Detailed
Analysis for Infectious Disease Diagnostics Market:
North America accounted for the largest share of the global
infectious disease diagnostics market. This largest share is attributed to the
presence of a highly developed healthcare system, increasing prevalence of
infectious diseases, the presence of a large number of leading national
clinical laboratories, and easy accessibility to technologically advanced
instruments in the region.
Read More in Detailed
(Infectious Disease Diagnostics Market): https://www.marketsandmarkets.com/PressReleases/infectious-disease-diagnostics.asp
No comments:
Post a Comment